



                                                                                                                                                                               
www.ghanamedj.org  Volume 52 Number 2 June 2018 94 
Recommendations for cervical cancer prevention and control in Ghana: public ed-
ucation and human papillomavirus vaccination  
Yvonne Nartey1, Philip Hill1, Kwabena Amo-Antwi2, Richard Asmah3, Kofi Nyarko4, Joel Yarney5, 
Nelson Damale6 and Brian Cox1 
 
Ghana Med J 2018; 52(2): 94-102 doi: http://dx.doi.org/10.4314/gmj.v52i2.6  
 
1Hugh Adam Cancer Epidemiology Unit, Department of Preventive and Social Medicine, University of Otago, 
Dunedin, Otago, New Zealand, 2Department of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospi-
tal, Kumasi, Ghana, 3Department of Medical Laboratory Sciences, School of Biomedical and Allied Health 
Sciences, University of Ghana, Legon, Greater Accra, Ghana, 4Department of Epidemiology and Disease 
Control, School of Public Health, University of Ghana, Accra, Greater Accra, Ghana, 5National Centre for 
Radiotherapy and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Greater Accra, Ghana, 
6Department of Obstetrics and Gynaecology, Korle Bu Teaching Hospital Accra, Greater Accra, Ghana 
 
Corresponding author:  Yvonne Nartey                                        E-mail:yvonnenartey69@gmail.com    
Conflict of interest: None declared  
 
SUMMARY 
Globally, cervical cancer is a major public health issue causing increasing morbidity and mortality especially in low- 
and middle-income countries where preventive and control measures are lacking. In Ghana, it is the most common 
cancer among women. Approaches to reduce the incidence and mortality of the disease in Ghana have had little suc-
cess due to lack of accurate data on the disease among other factors, to inform policies on prevention, early detec-
tion, diagnosis and treatment. Additionally, the lack of clear commitment, policy direction and resources has hin-
dered the scale-up of some of the initiatives implemented to curb the cervical cancer situation in Ghana. In this pa-
per, we make recommendations on cervical cancer education and human papillomavirus vaccination. A collabora-
tive approach is needed involving both private and government organizations, health professionals and the general 
public. Public education on cervical cancer and HPV vaccination needs to be delivered through a mixture of systems 
including both healthcare facilities and outreach programs, involving teachers, youth groups, community members 
and professional bodies. The vaccination of adolescents aged 10-14 years using the nonavalent HPV vaccine will be 
important in reducing the incidence and mortality of cervical cancer in Ghana. The integration of public education 
on cervical cancer prevention, HPV vaccination and screening programs into both medical and public health ser-
vices is critical in achieving high coverage of these programs.  
 
Funding: None 
Keywords: Cervical cancer, Education, HPV vaccination, Prevention, Ghana 
 
INTRODUCTION 
Cervical cancer is a significant public health issue 
worldwide. It is the fourth most common cancer among 
women with more than 85% of new cases of the disease 
occurring in low- and middle-incomes countries 
(LMICs).1 Cervical cancer is the most common cancer 
among women in Ghana.1 The incidence and mortality 
rates have recently been estimated in some regions.2, 3  
The age standardised incidence rate (world standard 
population) for the Greater Accra and Ashanti regions 
has been estimated to be 24.5 (95% CI: 22.9-26.1) and 
14.0 (95% CI: 12.9 – 15.1) per 100,000, respectively.3  
In Kumasi, cervical cancer account for 29.4% of all 
female cancers in 2012.4  
According to GLOBOCAN, 3,052 new cases and 1,556 
deaths from cervical cancer were recorded in Ghana in 
2012.1  
 
Human papillomavirus (HPV) infection has been shown 
to be a necessary initiator of cervical cancer but the in-
fection progresses to cancer only in a fraction of wom-
en. Cofactors associated with disease progression are 
not well understood in many LMICs including Ghana.  
 
We have conducted two studies to assess the incidence, 
mortality, survival rates and risk factors associated with 
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The first was a review of medical records of women 
diagnosed with cervical cancer from January 2010 to 
December 2013 at the Korle Bu Teaching Hospital 
(KBTH), Accra and the Komfo Anokye Teaching Hos-
pital (KATH), Kumasi.2,3,5    
 
Structured telephone interviews were also conducted for 
patients and relatives to gather further information on 
the outcome of the disease. The second study assessed 
the risk factors for cervical cancer in Ghana, using a 
hospital-based case-control study.2  
 
Women aged 18-95 years with newly diagnosed histo-
logically confirmed invasive cervical cancer were eligi-
ble to be cases. They had not received treatment for the 
disease and had been resident in Ghana for at least 3 
years. Controls were randomly selected from the same 
hospitals as the cases. They fulfilled all the eligibility 
criteria defined for the cases apart from those relating to 
diagnosis of cervical cancer.  
 
A structured questionnaire was administered to the 
women after which a request for a cervical smear was 
made for the assessment of cytological abnormalities 
and detection of HPV DNA to establish the HPV types 
present. The two studies were conducted between July 
2014 and May 2015. Ethical approval from the Univer-
sity of Otago Ethics (Health) Committee was obtained 
by the researchers. Additionally, the Ghana Health Ser-
vice Ethical Committee and the Committee on Human 
Research, Publication and Ethics of the Kwame Nkru-
mah University of Science and Technology (KNUST) 
and KATH gave approval for the study.  
 
Using the data from the review of medical records and 
telephone interviews, the incidence, mortality, and sur-
vival rates of women diagnosed with invasive cervical 
cancer were estimated. The incidence and mortality 
rates of cervical cancer were highest for women aged 
75-79 years and decreased at older ages in our study.2, 3 
At three years from diagnosis, overall disease-specific 
survival was 39%.5 Stage at presentation (Hazard ratio 
(HR) for stage IV compared with stage I was  7.8; 95% 
CI: 4.1-14.8) and histological type (HR for other histo-
logical types compared with squamous cell carcinoma 
was 1.4; 95% CI: 0.4-5.9, not statistically significant) 
were strong predictors of cervical cancer survival. Some 
forms of treatment were also associated with better sur-
vival than others.  
 
Many known established risk factors were associated 
with the occurrence of cervical cancer in the case-
control study. These included age, an increased number 
of pregnancies, higher parity and oral contraceptive use. 
2, 6, 7  
In addition, use of firewood for cooking, use of home-
made sanitary towels and having a polygamous husband 
were associated with an increased risk of cervical can-
cer. These associations have also been found in some 
other LMICs.8-10 Knowledge of HPV and cervical can-
cer was very low among women with and without cer-
vical cancer in our study.2  
 
A multi-level approach is required to address the burden 
of cervical cancer in Ghana. A national policy on cervi-
cal cancer tailored to the socio-economic and cultural 
context will need to be established if the disease is to be 
controlled. This approach needs to take into account the 
complexities of the disease, the barriers to healthcare 
access, the determinants of health, and the social and 
cultural factors that influence health. A national cervical 
cancer prevention and control program needs to be de-
veloped and implemented in Ghana.  
 
This should ideally include national policy development 
and program management structure, planning and prep-
aration, implementation, monitoring, and evaluation.11 
This national cervical cancer policy should include pre-
vention, early detection, diagnosis and treatment, and 
palliative care. The World Health Organization health 
system framework can be used to plan the program. 
Additionally, the National Cancer Control Strategy for 
Ghana can also be a starting point.12  
 
The aim of the current paper is to make recommenda-
tions in terms of public education and HPV vaccination 
for the prevention of cervical cancer.  
 
Prevention and control of cervical cancer in Ghana 
Public education 
Evidence from studies2, 3,13-16 conducted in Ghana indi-
cate that knowledge of HPV and other risk factors asso-
ciated with the development of cervical cancer is lim-
ited. However, studies conducted in well-educated 
women reported relatively good knowledge of cervical 
cancer17 but these women are generally at lower risk of 
cervical cancer.2 A cervical cancer educational program 
could be implemented as part of a national cervical can-
cer control program. This may be the most cost-
effective approach in reducing the burden of the dis-
ease.11 A mixture of systems can be used to deliver cer-
vical cancer education program: in healthcare facilities 
and in the community.  
 
There is lack of an effective curriculum, learning and 
teaching materials on comprehensive sexual and repro-
ductive education in schools including cervical cancer 
prevention in Ghana. For this to be achieved, collabora-
tion is needed between the Ministry of Education and 
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Such collaboration will need to develop a specific, 
structured, targeted, age-related and culturally appropri-
ate curriculum for adolescent sexual and reproductive 
health18 including cervical cancer education based on 
evidence from research. The development of the curric-
ulum should ideally involve individuals with various 
backgrounds in research on cervical cancer and sexual 
health.  
 
A review of 85 school-based sexual education programs 
suggested improvement in adolescent knowledge of 
STIs and recommended the use of curriculum-based 
programs in adolescent sexual and reproductive health 
education.19  
 
This could be implemented in schools, communities and 
health facilities. The content of the curriculum needs to 
include all aspects of sexual and reproductive health 
including the causes of cervical cancer, risk factors, 
signs and symptoms, prevention, HPV vaccination, 
screening and available health services. A pilot study 
can be conducted to test the curriculum and make 
changes when necessary. Misconceptions and beliefs 
about cervical cancer such as a perceived lack of availa-
ble treatment for the disease should be addressed if the 
disease is to be abated.  
 
Systematic reviews of school-based education programs 
in Africa have shown that significant change in adoles-
cents’ knowledge and altitude towards HIV/AIDS and 
other sexually transmitted infections (STIs) can be 
achieved.20, 21 School-based sexual and reproductive 
health education is one way to help adolescents recog-
nise risk and improve their sexual and reproductive 
health.22 A well-developed program including cervical 
cancer prevention can influence adolescents’ altitude, 
knowledge and behaviour on sexual and reproductive 
health greatly.18, 23 Cervical cancer education could ide-
ally begin at primary schools (late in primary school) as 
enrolment at primary school is high but decreases at the 
junior, senior and tertiary level (Figure 1).  
 
Recently, the Ghana Health Service launched an adoles-
cent health service policy and strategy to provide better 
direction and improve the effectiveness of adolescent 
health intervention in Ghana24 but an action plan for its 
implementation will be needed. Partnerships with young 
people are of great importance in designing and imple-
menting cervical cancer prevention education programs. 
The involvement of young people at the onset of a sexu-
al and reproductive education program develops trust 
and helps to identify some of the challenges (such as 
lack of a youth-friendly services) that need to be im-
proved for adolescent health programs to be effective.25  
 
This can build the capacity of young people in the area 
of advocacy and peer education. Partnerships with youth 
networks can also help provide training to volunteer 
peer educators to provide education to adolescents and 
women in the community using various media such as 
home visits, radio, television programs and theatre.  
 
Youth networks in Ghana such as The Global Youth 
Action Network and the Ghana Youth Development 
Network, if suitable, may be able to train educators at 
the community and household level. 
 
Many schools have some form of sexual and reproduc-
tive education program26 that can be expanded to in-
clude cervical cancer prevention education. Currently, 
there are some forms of sexual and reproductive educa-
tion programs at senior high school level. However, 
only a few students benefit from such education with 
most education programs focussing mainly or solely on 
human immunodeficiency virus (HIV) prevention.26  
 
Sexual and reproductive education programs at senior 
high schools have been incorporated into courses like 
Management in Living and Integrated Science at the 
senior high school level.26 However, Management in 
Living is an elective course and the majority of students 
do not take it.26 It would be important to have a com-
prehensive sexual and reproductive program including 
cervical cancer education as a stand-alone core subject 
for the majority of students to benefit.  
 
This could be continued at the tertiary level with inclu-
sion of breast and cervical screening education as part 
of the comprehensive sexual and reproductive education 
program. The establishment of clubs at schools to dis-
cuss adolescent health issues such as HPV infection and 
the prevention of cervical cancer will also play an im-
portant role in educating students about the disease.27 
 
It has been shown that the most effective sexual and 
reproductive programs are those led by teachers, health 
professionals, social workers and community mem-
bers.28 However, many require further training to deliver 
sexual and reproductive education to their students.26 
This could begin at teacher training with periodic work-
shops for teachers out of school. This pre-service and 
in-service training will be important to improve the 
skills of teachers in delivering adolescent sexual and 
reproductive education. 
 
The development of the curriculum to include cervical 
cancer prevention should aim at providing students with 
the knowledge, skills, and understanding to enhance 
positive attitudes towards sexuality and care for their 
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Educational information could be disseminated using a 
variety of media including seminars, media channels 
such as television, radio, newspapers, posters, role-
playing and drama, as well as interpersonal contact with 
healthcare professionals.  
 
Public cervical cancer education can take place at 
schools, workplaces, churches, mosques, market places 
and durbars for good coverage to be achieved – our 
study2 indicated that the majority of women preferred 
educational programmes at such venues. Education pro-
grams to target women in semi-urban and remote areas 
and those at increased risk of cervical cancer are also 
needed. 
 
One of the limitations of sexual and reproductive health 
education in schools is the difficulty in reaching indi-
viduals out-of-school. These are the individuals who are 
at highest risk of developing cervical cancer.2 For indi-
viduals out of school, education programs in the com-
munity can be beneficial. Community health nurses can 
be trained to provide organised cervical cancer educa-
tion programs in the community, do home visits and 
give talks at community festivals.  
Men usually serve as heads of families in Ghana, and 
drive most decision-making, including the seeking of 
healthcare from mainstream healthcare providers.29 
They will need to be involved in the educational pro-
gram if it is to be effective. Women’s groups in the 
community also need to be involved in cervical cancer 
prevention program and community volunteers may be 
trained to provide education on cervical cancer preven-
tion to their members and the wider community. The 
Ghana hairdressers and Beautician’s Association, and 
the National Tailors and Dressmakers Association 
among other professional bodies could also be involved 
in cervical cancer education programs incorporated into 
their meetings and examinations.  
 
Healthcare professionals could be upskilled to provide 
education on cervical cancer when they come into con-
tact with women during consultation, family planning, 








of cervical cancer 
prevention and 
control program 
Cervical cancer     
education program  
HPV vaccination of ado-
lescents aged 10-14 
years using the no-
navalent vaccine 
Hospital based and outreach programs 
 
- Hospital-based vaccination (delivered by 
trained nurses) 
- School-based vaccination (delivered by 
community health nurses) 
- CHPS compounds (delivered by community 
health nurses) 
-Community vaccination at selected centers 
(delivered by community health nurses) 
Hospital-based and outreach education pro-
grams 
 
Education at waiting areas of health facilities 
through health talks delivered by trained nurs-
es, Availability of poster and written materials 
at waiting areas of healthcare facilities. 
- School-based comprehensive adolescent sex-
ual and reproductive health program including 
cervical cancer prevention (delivered by 
trained teachers and peer educators) 
-Education in the community by community 
health nurses, community volunteers and peer 
educators 
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Additionally, efforts to improve the level of knowledge 
of HPV, risk factors, HPV vaccination and cervical 
screening requires increased involvement of the media 
and women who have survived the disease. Individuals 
are often strongly influenced by messages from some-
one living with or who has survived the disease. Addi-
tionally, the involvement of people with disability and 
head porter (kayayee) will potentially result in increased 
coverage among the at-risk groups.   
 
Implementation by District Health Management Teams 
in structured manner would ensure country-wide cover-
age, similar to immunization programs implemented in 
a similar fashion. Community Health Nurses have been 
trained to do childhood immunization and educate 
mothers at child welfare clinics countrywide. A similar 
approach would ensure good penetration and coverage.  
 
HPV vaccination 
The implementation of a national HPV vaccination pro-
gramme to vaccinate adolescent girls aged 10-14 years 
will need to be an integral component of the control and 
prevention of cervical cancer in Ghana. Results from 
some studies2,30-33 support licensing of the nonavalent 
HPV vaccine in Ghana. The vaccine provides immunity 
to the high-risk oncogenic HPV types that have been 
found to account for the majority of cervical cancer in 
Ghana.2, 30-33 The nonavalent HPV vaccine prevents 
infection against nine HPV types (6, 11, 16, 18, 31, 33, 
45, 52 and 58). The vaccine has been shown to be effi-
cacious, with an overall estimated rate of prevention of 
80% for precancerous lesions, and 90% and cervical 
cancer. 34 Both pre-licensure and post-licensure studies 
have shown the vaccine to be safe.35-39  
 
The three doses required may be an obstacle in the im-
plementation of HPV vaccination program in Ghana, 
however, two doses provide similar antibody levels as 
the three-dose schedule.40, 41 A two-dose regimen will 
increase HPV vaccine affordability and make for easier 
implementation. Because HPV vaccines are effective 
when given before sexual debut, the target age group 
should be young adolescents aged 10-14 years. Eco-
nomic modelling will be important in assessing the cost-
effectiveness of vaccinating girls aged 10-14 years.42  
 
A system to keep track of adolescents vaccinated and 
those who are yet to complete their doses is essential for 
the programme to be monitored and reduce the risk of 
the same person being vaccinated on several occasions. 
There are also other issues which need to be considered 
such as maintaining the cold chain, vaccine stock, vac-
cine safety and the monitoring of adverse effects. Expe-
rience from childhood immunization can be relied upon.  
Cost has prevented the introduction of the HPV vaccine 
in many LMICs. However, funding of the HPV vaccine 
by Global Alliance for Vaccines and immunization 
(GAVI) reduces the price of the vaccine (less than 
5USD per dose). 43 Donations from GAVI have also led 
to demonstration projects in some LMICs. With the 
current reduction of the price of HPV vaccines by GA-
VI, the Government of Ghana might take the opportuni-
ty to make the vaccine available to young adolescents. 
GAVI has supported governments in various countries 
including Ghana with demonstration projects in order to 
build capacity and infrastructure to deliver a HPV vac-
cination program.  
 
A HPV vaccine pilot program was launched in the 
Greater Accra, Central and Northern regions of Ghana 
in 2013. It has been estimated that over 33,000 primary 
school girls aged 10-14 were vaccinated with the quad-
rivalent HPV vaccine in Ghana.44 The results of this 
demonstration program will inform policy on HPV vac-
cination. The GAVI supported demonstration project is 
for a five-year period. However, efforts are being made 
by the government to extend it to ten years.44 
 
Due to low school attendance during later adolescence, 
particular for girls, vaccination programs in the commu-
nity will be needed. The use of established immuniza-
tion network such as those that deliver vaccination pro-
gram to infants and a network of sexual and reproduc-
tive services such as family planning may be able to be 
used to deliver HPV vaccine to adolescents.42 Thus, a 
mixture of services might be employed in Ghana involv-
ing both HPV vaccine delivery at health facilities and 
outreach programs.  
 
The HPV vaccination program could initially be rolled 
out in selected communities, preferably populations 
with characteristics associated with the highest inci-
dence rates, and gradually increased to cover the whole 
country. The target age group might receive HPV vac-
cination at a fixed healthcare facility in the selected 
communities. A central location for HPV vaccination 
might be established for girls out of school to be im-
munised. Thus, both school and community based vac-
cination programs is essential to improve coverage of at 
risk groups. 
 
Most sexual and reproductive health services are in-
volved in providing family planning and cervical 
screening services to women. It will be important for 
HPV vaccination programs to be integrated into these 
services. Although the primary target group for HPV 
vaccination is younger than users of current sexual and 
reproductive health services, these services provide con-




                                                                                                                                                                               
www.ghanamedj.org  Volume 52 Number 2 June 2018 99 
ers attend health services.42 Vaccination of infants in 
Ghana is possible as the Expanded Program on Immun-
ization (EPI) has maintained in place an infrastructure 
and logistics system. However, the safety and effective-
ness of HPV vaccines in infants are unknown.42 Never-
theless, HPV vaccination might be integrated into the 
EPI, not to vaccinate infants, but rather adolescents aged 
10-14 years. This could be followed by educating wom-
en about other vaccines that can be given at various 
stages of their children lives. 
 
The integration of HPV vaccination into the Communi-
ty-based Health planning and services (CHPS) program 
is also important. Community health nurses in CHPS 
compounds that provide maternal and childcare to 
women and adolescents could be trained to provide edu-
cation on cervical cancer and also HPV vaccination. 
The private sector is important in the health delivery 
system in Ghana. It is therefore important for both pri-
vate for profit and not for profit health providers to be 
included in cervical cancer education and HPV vaccina-
tion programs.  
 
Because the target population for HPV vaccination is 
different from that of current national vaccination pro-
grams, a school-based vaccination program is likely to 
be the most effective strategy.42 Vaccination can be 
done in schools similar to the pilot project and the 
community to reach a high number of adolescents (aged 
10-14 years). School-based HPV vaccination programs 
may provide new incentives for the expansion and im-
provement of adolescent health services.11 However, 
having an immunization team present at a school for 
several days may be resource intensive, thus, the estab-
lishment of a school health programs with a provider 
would be helpful.11  
 
The school health provider can be trained to provide 
HPV vaccination to the target age group. Additionally, 
the use of schools as HPV vaccination sites and encour-
aging school children to bring those aged 10-14 years 
who have left school to the vaccination sites could be 
evaluated in demonstration projects.42There are socio-
cultural issues which need to be considered for HPV 
vaccination program. Because HPV vaccines are for 
STIs their acceptance and marketing may be problemat-
ic.  
 
Additionally, the stigmatisation of young women with 
respect to a women–only vaccination program also 
needs to be avoided.42 The introduction of HPV vac-
cination among adolescents may, therefore, be misinter-
preted as an attempt to reduce fertility rates.42, 45 There 
has been concern that vaccination may enhance adoles-
cent promiscuity by encouraging more at-risk sex.46-48 
However, this conjecture has not been supported by 
studies that have reported no statistically significant 
increase in sexual behaviour and STIs in adolescents 
after HPV vaccination.49, 50 Although the acceptance of 
the HPV vaccine has been shown to be generally high in 
many countries51-55, these social concerns need to be 
considered if high coverage is to be achieved in Ghana.  
 
The education of adolescents and parents is critical in 
reducing misconceptions about HPV vaccination. Stud-
ies are needed to assess the acceptability of the vaccine 
and any misconceptions among the Ghanaian popula-
tion. Multiple stakeholders need to be involved at the 
appropriate stages of advocacy and social communica-
tion. Any attempt to implement a national HPV vaccina-
tion programme should involve clinicians, parents, 
teachers and other relevant stakeholders to obtain wide-
spread support.  
 
Training of individuals to coordinate and head the pro-
gram will be required with government sponsorship. 
The Ghana Ministry of Health (MOH) needs to be the 
lead agent in coordinating the prevention and control of 
cervical cancer in Ghana. The establishment of a multi-
disciplinary team and stakeholder’s advisory groups 
with representatives from various groups and service 
providers will be necessary.11 Working groups can be 
established to oversee the various aspect of the program.  
 
The Department of Disease Control and Prevention, 
Ghana Health Service, could be a base for cervical can-
cer prevention and control program in Ghana. 
Collaboration with the Family Health division will 
ensure high impact and efficiency. Continued evaluation 
of cervical cancer education and the HPV vaccination 
program is likely to be necessary to enhance its effec-
tiveness and ensure that the program achieves its objec-
tives and reaches the target population.  
 
Funding is a major challenge for cervical cancer preven-
tion and control in Ghana and many other countries in 
Africa. Some government funds and technical support 
would need to be allocated for the cervical cancer pre-
vention and control program.11 Partnership with private 
companies is a way of improving funding for cervical 
cancer control; similar to that achieved for cardiovascu-
lar disease through the establishment of the National 
Cardiothoracic Centre. Additionally, support from indi-
viduals, private companies, and multinational compa-
nies might be sought to complement government fund-
ing in the provision of infrastructure, logistics and hu-
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Incentives, such as awards and tax reductions, may be 
introduced for the involvement of individuals, private 
and multinational companies for cervical cancer preven-
tion and control. 56 
 
Volunteering is also a way for students and individuals 
to make a positive difference for others and society, and 
also gain valuable experience and skills for their various 
careers. Volunteers could also reduce costs and improve 
access to preventive services for the majority of Ghana-
ians. Volunteers have been used in New Zealand, Unit-
ed Kingdom, United States of America, and other coun-
tries to improve health services.57 This can be incorpo-
rated into cervical prevention and control programs in 
Ghana. 
  
Cervical cancer prevention and control needs focussed 
infrastructure including human resources, vaccine stor-
age facilities, laboratories, and treatment centres which 
are scarce in Ghana. Training of health care workers to 
reduce the shortage of health professionals in Ghana is 
also an urgent priority for a national cervical cancer 
control policy to be effective.56 This might be achieved 
by training some health professionals such as communi-
ty health nurses which is less expensive.  
 
The provision of incentives as well as mentorship op-
portunities might help reduce the migration overseas of 
health professionals. Career opportunities for advance-
ment and specialisation will be important. Further re-
ward may be given to health professionals who accept 
posting to rural areas to address the staff shortages. All 
these initiatives would support a cervical cancer educa-
tion and HPV vaccination program to reduce the burden 
of the disease in Ghana. 
 
CONCLUSION 
Cervical cancer is a very important public health issue 
in Ghana. There are opportunities to reduce the burden 
of the disease through education, HPV vaccination, 
screening and treatment of the disease. Achieving this 
requires a coordinated systematic approach from the 
government, private agencies, health professionals and 
the general population. We recommend a whole-of-
government approach involving all the relevant gov-
ernmental agencies and other key stakeholders to devel-
op an integrated approach for cervical cancer control 
and prevention in Ghana.  
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